Westminster Health Forum

Antimicrobial resistance - progress on the UK strategy and coordinating a global response

Morning, Thursday, 20th February 2020

Glaziers Hall, 9 Montague Close, London SE1 9DD


This conference focuses on next steps for tackling antimicrobial resistance (AMR) in the UK - and the global response to AMR.

It will be an opportunity to assess priorities for improving infection prevention and control as stakeholders in health care and research begin implementation of Public Health England’s Infectious Disease Strategy 2020-2025.

Areas for discussion include:

  • Supporting the infection prevention workforce;
  • Developing innovative diagnostic technologies;
  • Reducing the transmission of resistant bacteria; and
  • The Strategy’s goal to make the UK a world leader in tackling AMR.

Further sessions will consider the progress of research into AMR, with discussion on funding, impact and supporting innovation to address AMR in humans, animals, and the environment.

The agenda includes keynote addresses from:

  • Professor Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance, World Health Organisation;
  • Professor Dame Sally Davies, Previous Chief Medical Officer for England and newly-appointed UK Special Envoy on AMR for UK Government; and
  • Professor Brian Ferguson, Chief Economist, Public Health England.

There will be further contributions from: Dr Jessica Boname, Medical Research Council; Arlene Brailey, Antibiotic Research UK; Rose Gallagher, Royal College of Nursing; Dr Roger Harrison, University of Manchester; Dr Kitty Healey, Department for Environment, Food and Rural Affairs; Professor Hilary Thomas, KPMG; Dr Michael Weinbren, Sherwood Forest NHS Foundation Trust; Doris-Ann Williams, BIVDA  and Adam Zerda, Becton Dickinson.

The agenda in summary

  • Strengthening global coordination to tackle AMR;
  • Collaboration, encouraging innovation, and financial incentives for protecting existing antimicrobials and advancing new development;
  • Prevention and control of infections, and the public health benefits of tackling AMR;
  • Appropriate prescribing and reducing healthcare-associated infections - improving diagnostics, managing patient expectations, and engaging with clinicians, vets, and farmers; and
  • Meeting the goals of the UK AMR strategy.

Policymakers attending

Westminster Health Forum conferences typically attract strong interest from policymakers. This seminar will be an opportunity for stakeholders to engage with officials who have reserved places representing: DHSC; the MHRA; DEFRA; the Office for Life Sciences; the Animal and Plant Health Agency; BEIS; DIT; Government Legal Department; and HM Treasury.

Keynote Speaker

Professor Dame Sally Davies

Previous Chief Medical Officer for England and UK Special Envoy on AMR for UK Government

Supported by

Keynote Speakers

Professor Dame Sally Davies

Previous Chief Medical Officer for England and UK Special Envoy on AMR for UK Government

Professor Hanan Balkhy

Assistant Director-General, Antimicrobial Resistance, World Health Organisation

Professor Brian Ferguson

Chief Economist, Public Health England


Dr Roger Harrison

Senior Lecturer, Division of Population Health, Health Services Research and Primary Care, University of Manchester

Dr Kitty Healey

Head, Antimicrobial Resistance Policy and Surveillance, Veterinary Medicines Directorate, Department for Environment, Food and Rural Affairs

Dr Michael Weinbren

Consultant Microbiologist, Kingsmill Hospital, Sherwood Forest NHS Foundation Trust

Professor Hilary Thomas

Chief Medical Adviser and Member, Centre of Excellence in Healthcare and Life Sciences, KPMG

Doris-Ann Williams

Chief Executive, BIVDA

Arlene Brailey

Patient Support Officer, Antibiotic Research UK

Adam Zerda

Director, AMR Strategy and Development, Becton Dickinson

Rose Gallagher

Professional Lead, Infection Prevention and Control, Royal College of Nursing

Dr Jessica Boname

Head of Programme, Antimicrobial Resistance, Medical Research Council, UK Research and Innovation